Indeed, the overexpression of DUSP1 rendered non-small cell lung carcinoma (NSCLC) H460 cells resistant to cisplatin, while its downregulation sensitized these cells to cisplatin-induced cell death. This evidence concerns the gene DUSP1 and non-small cell lung carcinoma.